ATE479744T1 - Verfahren zur herstellung differenzierter vogelzellen und an der aufrechterhaltung der pluripotenz beteiligter gene - Google Patents
Verfahren zur herstellung differenzierter vogelzellen und an der aufrechterhaltung der pluripotenz beteiligter geneInfo
- Publication number
- ATE479744T1 ATE479744T1 AT07727050T AT07727050T ATE479744T1 AT E479744 T1 ATE479744 T1 AT E479744T1 AT 07727050 T AT07727050 T AT 07727050T AT 07727050 T AT07727050 T AT 07727050T AT E479744 T1 ATE479744 T1 AT E479744T1
- Authority
- AT
- Austria
- Prior art keywords
- avian
- stem cells
- cells
- genes involved
- differentiated
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 241000271566 Aves Species 0.000 abstract 5
- 210000000130 stem cell Anatomy 0.000 abstract 5
- 210000004027 cell Anatomy 0.000 abstract 3
- 239000013604 expression vector Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 101100445364 Mus musculus Eomes gene Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 101100445365 Xenopus laevis eomes gene Proteins 0.000 abstract 1
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229960004854 viral vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Reproductive Health (AREA)
- Plant Pathology (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0602597A FR2898908A1 (fr) | 2006-03-24 | 2006-03-24 | Procede de preparation de cellules aviaires differenciees et genes impliques dans le maintien de la pluripotence |
| PCT/EP2007/052572 WO2007110341A1 (fr) | 2006-03-24 | 2007-03-19 | Procede de preparation de cellules aviaires differenciees et genes impliques dans le maintien de la pluripotence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE479744T1 true ATE479744T1 (de) | 2010-09-15 |
Family
ID=37055981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07727050T ATE479744T1 (de) | 2006-03-24 | 2007-03-19 | Verfahren zur herstellung differenzierter vogelzellen und an der aufrechterhaltung der pluripotenz beteiligter gene |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20090311789A1 (de) |
| EP (2) | EP2007882B1 (de) |
| JP (1) | JP5124748B2 (de) |
| AT (1) | ATE479744T1 (de) |
| AU (1) | AU2007229556A1 (de) |
| CA (1) | CA2647806A1 (de) |
| DE (1) | DE602007008863D1 (de) |
| DK (1) | DK2007882T3 (de) |
| ES (1) | ES2351620T3 (de) |
| FR (1) | FR2898908A1 (de) |
| WO (1) | WO2007110341A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2657590T3 (es) | 2010-11-23 | 2018-03-06 | Curna, Inc. | Tratamiento de enfermedades relacionadas con nanog mediante inhibición del transcrito antisentido natural a nanog |
| FR3008992A1 (fr) | 2013-07-25 | 2015-01-30 | Agronomique Inst Nat Rech | Procede de selection d'une lignee cellulaire permissive pour la replication de virus aviaires |
| JP2016158577A (ja) * | 2015-03-03 | 2016-09-05 | 富士フイルム株式会社 | 細胞コロニー検出装置および方法並びにプログラム |
| JP6925931B2 (ja) | 2017-10-20 | 2021-08-25 | 日本スピンドル製造株式会社 | バッチ式の混練機、及びバッチ式の混練機における羽根部の交換方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5456357A (en) | 1994-07-07 | 1995-10-10 | Wenner; John W. | Nestable bucket and carrier |
| FR2726003B1 (fr) * | 1994-10-21 | 2002-10-18 | Agronomique Inst Nat Rech | Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires |
| US5914268A (en) | 1994-11-21 | 1999-06-22 | National Jewish Center For Immunology & Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| WO1999049029A1 (en) | 1998-03-20 | 1999-09-30 | Benitec Australia Ltd | Control of gene expression |
| AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
| DE19956568A1 (de) | 1999-01-30 | 2000-08-17 | Roland Kreutzer | Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens |
| DE10160151A1 (de) | 2001-01-09 | 2003-06-26 | Ribopharma Ag | Verfahren zur Hemmung der Expression eines vorgegebenen Zielgens |
| DE10100586C1 (de) | 2001-01-09 | 2002-04-11 | Ribopharma Ag | Verfahren zur Hemmung der Expression eines Ziegens |
| EP1272630A2 (de) | 2000-03-16 | 2003-01-08 | Genetica, Inc. | Methoden und zusammensetzungen zur interferenz durch rna |
| MXPA02009069A (es) | 2000-03-17 | 2004-04-05 | Benitec Australia Ltd | Silenciamiento genetico. |
| PT1309726E (pt) | 2000-03-30 | 2010-03-08 | Whitehead Biomedical Inst | Mediadores de interferência por rna específicos de sequência de rna |
| US6458589B1 (en) | 2000-04-27 | 2002-10-01 | Geron Corporation | Hepatocyte lineage cells derived from pluripotent stem cells |
| US20040259247A1 (en) | 2000-12-01 | 2004-12-23 | Thomas Tuschl | Rna interference mediating small rna molecules |
| WO2003035869A1 (de) | 2001-10-26 | 2003-05-01 | Ribopharma Ag | Verwendung einer doppelsträngigen ribonukleinsäure zur gezielten hemmung der expression eines vorgegebenen zielgens |
| CA2452653A1 (en) | 2001-07-17 | 2003-01-30 | Anne Josephine Milner | Silencing of gene expression by sirna |
| US20030198627A1 (en) | 2001-09-01 | 2003-10-23 | Gert-Jan Arts | siRNA knockout assay method and constructs |
| DE10163098B4 (de) | 2001-10-12 | 2005-06-02 | Alnylam Europe Ag | Verfahren zur Hemmung der Replikation von Viren |
| WO2003035870A1 (de) | 2001-10-26 | 2003-05-01 | Ribopharma Ag | Medikament zur behandlung eines pankreaskarzinoms |
| WO2003035083A1 (de) | 2001-10-26 | 2003-05-01 | Ribopharma Ag | Medikament zur behandlung einer fibrotischen erkrankung durch rna interferenz |
| CN1608133A (zh) | 2001-10-26 | 2005-04-20 | 里伯药品公司 | 双链核糖核酸用于治疗正(+)链rna病毒感染的用途 |
| DE10230996A1 (de) | 2001-10-26 | 2003-07-17 | Ribopharma Ag | Medikament zur Behandlung eines Pankreaskarzinoms |
| AU2003260370B2 (en) | 2002-08-05 | 2008-05-22 | Silence Therapeutics Gmbh | Further novel forms of interfering RNA molecules |
| WO2004019973A1 (en) | 2002-08-14 | 2004-03-11 | Atugen Ag | Use of protein kinase n beta |
| EP2072619A1 (de) | 2002-10-18 | 2009-06-24 | Silence Therapeutics Aktiengesellschaft | Neuer Faktor für Metastase und Verwendungen davon |
| WO2005000320A2 (en) | 2003-06-27 | 2005-01-06 | Atugen Ag | Use of double-stranded ribonucleic acid for inducing cell lysis |
-
2006
- 2006-03-24 FR FR0602597A patent/FR2898908A1/fr not_active Withdrawn
-
2007
- 2007-03-19 WO PCT/EP2007/052572 patent/WO2007110341A1/fr not_active Ceased
- 2007-03-19 AT AT07727050T patent/ATE479744T1/de not_active IP Right Cessation
- 2007-03-19 JP JP2009500839A patent/JP5124748B2/ja not_active Expired - Fee Related
- 2007-03-19 ES ES07727050T patent/ES2351620T3/es active Active
- 2007-03-19 CA CA002647806A patent/CA2647806A1/fr not_active Abandoned
- 2007-03-19 DK DK07727050.2T patent/DK2007882T3/da active
- 2007-03-19 EP EP07727050A patent/EP2007882B1/de not_active Not-in-force
- 2007-03-19 EP EP10170872A patent/EP2292739B1/de not_active Not-in-force
- 2007-03-19 US US12/294,030 patent/US20090311789A1/en not_active Abandoned
- 2007-03-19 AU AU2007229556A patent/AU2007229556A1/en not_active Abandoned
- 2007-03-19 DE DE602007008863T patent/DE602007008863D1/de active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2292739A1 (de) | 2011-03-09 |
| DK2007882T3 (da) | 2010-12-20 |
| US20090311789A1 (en) | 2009-12-17 |
| JP5124748B2 (ja) | 2013-01-23 |
| EP2007882B1 (de) | 2010-09-01 |
| FR2898908A1 (fr) | 2007-09-28 |
| ES2351620T3 (es) | 2011-02-08 |
| CA2647806A1 (fr) | 2007-10-04 |
| EP2292739B1 (de) | 2012-09-12 |
| EP2007882A1 (de) | 2008-12-31 |
| JP2009529899A (ja) | 2009-08-27 |
| WO2007110341A1 (fr) | 2007-10-04 |
| AU2007229556A1 (en) | 2007-10-04 |
| DE602007008863D1 (de) | 2010-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE473278T1 (de) | Verfahren und zusammensetzungen zur herstellung rekombinanter proteine unter verwendung eines gens für trna | |
| DK1682667T3 (da) | RNA-virus afledt plantekspressionssystem | |
| EP2395091A3 (de) | Pflanzen mit verbesserten Ertragseigenschaften und Verfahren zu deren Herstellung | |
| DE602004019304D1 (de) | Genexpressionsmethode | |
| AU2012264606A1 (en) | Transcription terminator sequences | |
| NZ595476A (en) | Plant snf1-related protein kinase gene | |
| EP2998401A3 (de) | Pflanzen mit verbesserten ertragseigenschaften und verfahren zur herstellung davon | |
| ATE545700T1 (de) | Verfahren zur verbesserung der transformationseffizienz unter verwendung eines pulvers | |
| WO2014059275A3 (en) | Process for producing gougerotin employing streptomyces microflavus strains | |
| MX2010008052A (es) | Plantas que tienen rasgos aumentados relacionados con el rendimiento y un metodo para obtenerlas. | |
| RU2006145713A (ru) | Способ продукции пуриновых нуклиозидов и нуклиотидов методом ферментации с использованием бактерий, принадлежащих к роду escherichia или bacillus | |
| WO2009069381A1 (ja) | フラビンアデニンジヌクレオチド結合型グルコース脱水素酵素遺伝子が導入された形質転換体、及び該形質転換体を用いたフラビンアデニンジヌクレオチド結合型グルコース脱水素酵素の製造法 | |
| ATE555196T1 (de) | Wärmebeständige duplexspezifische nuklease | |
| CN102757960B (zh) | 一种扩增未知序列的半随机pcr技术及其引物和试剂盒 | |
| ATE479744T1 (de) | Verfahren zur herstellung differenzierter vogelzellen und an der aufrechterhaltung der pluripotenz beteiligter gene | |
| CN101402943A (zh) | 一种体外诱导和培养多潜能干细胞的方法 | |
| EP2835427A3 (de) | Pflanzen mit verbesserten Ertragseigenschaften und Verfahren zur Herstellung davon | |
| DE502006006865D1 (de) | Neue dehydrogenasen, deren derivate und ein verfahren zur herstellung von optisch aktiven alkanolen | |
| DE602005017252D1 (de) | Verfahren zur amplifikation von nukleinsäuren mittels promotor-templates | |
| AU2007208928A8 (en) | Transgenic plant transformed with stress-responsive gene | |
| CN109825501A (zh) | 一种来源于拟南芥的长链非编码rna t5120及其用途 | |
| DE602005017034D1 (de) | Signalpeptid zur herstellung eines polypeptids | |
| ATE522543T1 (de) | Verfahren zur herstellung von reifem, rekombinantem milben-i-allergen | |
| KR20060107060A (ko) | 한국산 오이모자이크 바이러스 유래 2b유전자를 이용한 식물체내에서의 외래 유전자의 발현을 증대시키는 방법 | |
| WO2009003429A3 (en) | Method of regulation of biomass production in plants, dna sequences and method of preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |